Trials / Completed
CompletedNCT05347004
A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food
The Effect of Food on the Pharmacokinetics of a BI 425809 Tablet Formulation Administered as a Single Dose With and Without Food to Healthy Subjects (an Open-label, Randomised, Two-period, Two-sequence Crossover Trial)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the potential effect of food on the pharmacokinetics of BI 425809 following administration of the intended Commercial Formulation (iCF) with food (Test treatment, T) and without food (Reference treatment, R).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 425809 | BI 425809 |
Timeline
- Start date
- 2022-10-25
- Primary completion
- 2022-12-28
- Completion
- 2022-12-28
- First posted
- 2022-04-26
- Last updated
- 2026-04-20
- Results posted
- 2026-04-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05347004. Inclusion in this directory is not an endorsement.